Process Development
OUR FOCUS IN PROCESS DEVELOPMENT IS ON E. COLI AND PICHIA PRODUCTION TECHNOLOGY
Solutions for meeting Large-Scale Needs
Richter BioLogics possesses extensive experience in developing and optimizing processes for producing recombinant proteins, plasmid DNA, and vaccines.
Our focus is on E.coli and Pichia production technology. Whether the starting point is the cDNA sequence of your target molecule or a preliminary small-scale process, we reliably carry your project to fruition by implementing large-scale, GMP-compliant manufacture. Interdisciplinary teams comprising experts on process development, analytics, and large-volume production ensure smooth scale-up. Small-scale process characterization and validation support round out our capabilities.
Our focus is on E.coli and Pichia production technology. Whether the starting point is the cDNA sequence of your target molecule or a preliminary small-scale process, we reliably carry your project to fruition by implementing large-scale, GMP-compliant manufacture. Interdisciplinary teams comprising experts on process development, analytics, and large-volume production ensure smooth scale-up. Small-scale process characterization and validation support round out our capabilities.
strain and fermentation development services
We make available our considerable expertise on developing strains based on E.coli host systems to produce peptides, proteins (soluble and insoluble), plasmid DNA products, and vaccines. The USP development capabilities at Richter BioLogics include the full range of leading-edge fermentation strategies for batch and fed-batch concepts based on microbial hosts like E.coli and yeast.
